Risk for transfusion-transmitted infectious diseases in Central and South America

Emerging Infectious Diseases

Volumn 4, Issue 1, 1998, Pages 5-11

  Schmunis, Gabriel A ^a   Zicker, Fabio ^a   Pinheiro, Francisco ^a   Brandling Bennett, David ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CENTRAL AMERICA; DISEASE TRANSMISSION; HEALTH CARE COST; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; INFORMATION SYSTEM; REVIEW; SCREENING; SOUTH AMERICA; SYPHILIS; TRYPANOSOMA CRUZI;

EID: 0031852683     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0401.980102     Document Type: Review

References (24)

1. Linares J, Vinelli E, editors. Taller Latinoamericano de servicios de transfusión sanguínea y óptimo uso de los recursos. Cruz Roja Finlandesa; 1994. p. 167.
2. Organización Panamericana de la Salud. Taller para el control de calidad de sangre en transfusiones: serología para la detección de Chagas, hepatitis B y C, sífilis y HIV/SIDA. Document OPS/HPC/HCT/94.42.
3. Organización Panamericana de la Salud. Países andinos. Taller sobre control de calidad de sangre en transfusiones: serología para la detección de hepatitis B y C, sífilis, tripanosomiasis americana y VIH/SIDA. Document OPS/HCP/HCT/95-61.
4. Organización Panamericana de la Salud. Simposio internacional sobre control de calidad en bancos de sangre del Cono Sur y de Brasil. Informe final OPS/ HCP/HCT/95.55.
5. Organización Panamericana de la Salud. Taller sobre control de calidad en serología de bancos de sangre. OPS/HCP/HCT/96/79.
6. Ministerio de Salud, Chile. Diagnóstico de la situación de los bancos de sangre y medicina transfusionál en Chile 1993. Santiago, Chile: La Ministerio; 1995. Ser Inf Téc No.14.
7. Pan American Health Organization. Health conditions in the Americas. Washington (DC): The Organization; 1994. PAHO Sci Pub No. 549.
8. Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Eng J Med 1995;333:1721-5.
9. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Eng J Med 1996;334:1685-90.
10. Van de Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
11. Andrade ANS, Martelli CMT, Luquetti AO, Oliveira OS, Almeida e Silva S, Zicker F. Triagem sorologica ra o Trypanosoma cruzi entre doadores de sangue do Brasil central. Bol Oficina Sanit Panam 1992;113:19-27.
12. Lorca MH, Child RB, Garcia AC, Silva MG, Osorio JS, Atias M. Evaluación de reactivos comerciales empleados en el diagnóstico de la enfermedad de Chagas en bancos de sangre de Chile. I Selección de reactivos. Rev Med Chile. 1992;120:420-6.
13. Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-9.
14. Gocke DJ. A prospective study of post-transfusional hepatitis. JAMA 1972;219:1165-70.
15. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-9.
16. World Health Organization. The control of Chagas disease. Geneva: WHO Tech Rep Ser No.811:32;990.
17. National Institutes of Health. Infectious disease testing for blood transfusion. NIH Consens Statement 1995;13:13-4.
18. Schmunis GA. Trypanosoma cruzi, the etiologic agent of Chagas disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991;31:547-55.
19. Schmunis GA. American trypanosomiasis as a public health problem. Chagas disease and the nervous system. PAHO Sci Pub 994;547:3-29.
20. Pedersen C, Lindhardt BO, Jensen BL, Lavritzen E, Gerstoft J, Dickmeiss E, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989;299:154-7.
21. Alter M. Residual risk of transfusion associated hepatitis. In: Program and Abstracts of the National Institutes of Health Development Conference on Infectious Diseases Testing for Blood Transfusions. 1995 Jan 9-11; Bethesda (MD): National Institutes of Health;1995. p. 23-7.
22. Busch MP. Incidence of infectious disease markers in blood donors, implications for residual risk of viral transmission by transfusion. In: Program and Abstracts of the National Institutes of Health Development Conference; 1995. Jan 9-11; Bethesda (MD): National Institutes of Health; 1995. P. 29-30.
23. Hamerschlak N, Pasternak J, Amato Neto V, Carvalho MB, Guerra CS, Coscina AL, et al. Chagas' disease, an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop 1997;30:205-9.
24. McFarland W, Mvere D, Shandera W, Reingold A. Epidemiology and prevention of transfusion-associated human immunodeficiency virus transmission in sub-Saharan Africa. Vox Sang 1997;72:85-92.